Trial Profile
A Phase I Study Of ZD 1839 In Combination With Radiation And Chemotherapy In Locally Advanced Squamous Cell Carcinoma Of The Head And Neck
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 01 Feb 2013
Price :
$35
*
At a glance
- Drugs Gefitinib (Primary) ; Cisplatin
- Indications Head and neck cancer
- Focus Adverse reactions
- 26 Sep 2005 New trial record.